Behind the Paper
The real stories behind the latest research papers, from conception to publication, the highs and the lows
Phage therapy for severe sepsis: where to next?
There is new optimism for phage therapy, an approach that has been with us for 100 years and is now being embraced anew. A rigorous clinical and biological approach will serve us well and effective partnerships between government, industry and the academy are essential.
Building a sustainable phage biobank – trials and tribulations
In an ideal world, a phage biobank would be a facility that serves as a primary research and therapeutic development resource for researchers studying critical infection, as well as to the wider community of infectious diseases, industry and biotech with an interest in critical infection.
